Table 2.
Aspirin (only) | Placebo | Relative risk | Interaction P value | |
---|---|---|---|---|
Age (years): | ||||
45-49 | 0/1447 (0.0) | 1/1502 (0.7) | NA | 0.85 |
50-54 | 3/1905 (1.6) | 0/1899 (0.0) | NA | |
55-59 | 4/1663 (2.4) | 11/1812 (6.1) | 0.40 | |
60-64 | 7/1811 (3.9) | 9/1756 (5.1) | 0.99 | |
65-69 | 4/1279 (3.1) | 5/1102 (4.5) | 0.59 | |
Systolic blood pressure (mm Hg): | ||||
<130 | 2/2688 (0.7) | 6/2687 (2.2) | 0.41 | 0.006 |
130-145 | 2/2663 (0.8) | 10/2582 (3.9) | 0.21 | |
>145 | 14/2754 (5.1) | 10/2802 (3.6) | 1.42 | |
Cholesterol concentration (mmol/l): | ||||
<5.9 | 3/2808 (1.1) | 12/2837 (4.2) | 0.20 | 0.036 |
5.9-6.7 | 7/2674 (2.6) | 8/2345 (3.4) | 0.90 | |
>6.7 | 8/2471 (3.2) | 6/2748 (2.2) | 1.53 |
NA: no events in one treatment group.